South Korean solar inverter makers have jointly launched a new association of inverter manufacturers to coordinate domestic production, safeguard local expertise, and address import-driven market ...
Zelestra has signed a PPA with technology giant Microsoft to sell power generated at a 95.7MW solar PV portfolio.
SMA Solar AG (S92G) has delivered a 169.140% change over the past year, with a 52-week range between 11.850 and 35.860. What Is the Average Daily Trading Volume of SMA Solar AG (S92G)? The average ...
Asian Power on MSN
Solar PV and inverters market to reach $115.8b by 2030
APAC will lead this growth. The global solar PV modules and inverters market is forecast to reach $115.8 billion by 2030, ...
Novartis wins FDA approval for Itvisma, a one-time gene therapy offering broader SMA treatment with sustained motor function ...
Onasemnogene abeparvovec-brve is the first gene replacement therapy approved for SMA patients aged 2 years and older, expanding access beyond infants. Phase 3 trials demonstrated significant motor ...
Explore how smart inverters and flexible interconnection can cut delays, lower costs, and unlock the next phase of ...
The FDA has approved Itvisma (onasemnogene abeparvovec-brve) to treat children two years and older, teens, and adults living with spinal muscular atrophy (SMA). It is indicated for patients with a ...
Zacks Investment Research on MSN
FDA Greenlights Novartis' Gene Replacement Treatment for SMA
Novartis NVS obtained FDA approval for onasemnogene abeparvovec-brve, a gene replacement therapy, for children two years and ...
The U.S. Food and Drug Administration has approved Itvisma as the first gene therapy for spinal muscular atrophy patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback